Faye M. Johnson

Faye M. Johnson, M.D., Ph.D., is a faculty member in the Department of Thoracic-Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, under the Division of Cancer Medicine. She leads a research laboratory focused on signal transduction pathways in lung, head and neck, and HPV-positive cancers, with a strong emphasis on kinase inhibitors and resistance mechanisms.

Research Interests: Dr. Johnson's research centers on understanding the molecular basis of sensitivity and resistance to targeted therapies. Her work integrates genomics, proteomics, and drug screening to identify effective treatments and combinatorial strategies. Key areas include the role of NOTCH1 mutations in PI3K/mTOR pathway dependency, PLK1 inhibitor sensitivity in mesenchymal NSCLC, and Aurora kinase inhibitors in HPV+ cancers.

Recent Research Trends: Her recent publications highlight translational studies using large-scale compound screens, integrated omics analyses, and functional validation in cancer cell lines. These efforts aim to bridge basic discoveries with clinical applications in precision oncology.

Scientific Awards: No specific awards are mentioned in the provided text.

Advising and Grants: Dr. Johnson leads an active research laboratory, indicating she mentors research trainees and secures grant funding to support her projects. Although specific grants and students are not listed, her lab's scope suggests involvement in predoctoral and postdoctoral training as well as NIH or institutional grant support.

Labs and Teams: She heads a research laboratory at MD Anderson focused on molecular oncology and therapeutic response. Her team conducts high-throughput drug screening, molecular profiling, and functional studies to advance targeted cancer therapies.